Join the INSEAD Basel Committee and fellow alumni for a unique perspective and intimate exchange of views on the global pharma M&A boom.
The Pharma M&A Frenzy: Industry Insider View, April 15, 2015, Basel
Since the start of 2014 the global healthcare sector has seen $475bn of mergers and acquisitions. This represents a record level for the industry, higher even than the megamergers of the late 1990s and early 2000s. Almost $70bn in deals have been announced so far this year, the strongest start to a year in over a decade. Analysts and banker predict more to come but investors may be starting to ask tougher questions about valuations.
What is driving the M&A boom? Structural changes in the industry? A greater willingness to make clear choices? Cheap financing? Tax optimization? What will the future of the industry look like? Get the answers from Marvelle Sullivan Berchtold who is uniquely positioned as Novartis’ Global Head of M&A to provide analysis and an insider view. Novartis has recently completed multiple billion Swiss Franc deals to sharpen its focus. This included an innovative and complex asset swap with GSK which bankers called “an elegant set of transactions”.
| Marvelle Sullivan BerchtoldGlobal Head of M&A, Novartis Group
Ms. Sullivan Berchtold is the Global Head of M&A for the Novartis Group. Since joining Novartis, she has represented the company in over $100 billion of transactions. Most recently, Marvelle led the Novartis Portfolio Transformation, which included the sale of Novartis Animal Health to Eli Lilly, the sale of Diagnostics to Grifols, the sale of the flu vaccines business to CSL (pending) and the three-part transaction with GSK (the acquisition of GSK’s oncology portfolio, the sale of Novartis ex-flu Vaccines business and the formation of the Consumer Health Joint Venture). |
| Key FactsWhen: Wednesday, April 15 2015 from 18:30 to 20:00 followed by cocktails
Where: Zunftsaal at Restaurant Schlüsselzunft, Freie Strasse 25, 4001 Basel, Switzerland Tickets: Swiss NAA Members CHF 60 / Non-Members and guests CHF 80 Registration Online at www.amiando.com/pharma15 INSEAD Alumni Association Switzerland Marc Galin, MBA’99J, Basel Chapter President Matthias Schneider, MBA’98D, Event Organizer |
INSEAD Alumni Association Switzerland
Marc Galin, MBA’99J, Basel Chapter President
Matthias Schneider, MBA’98D, Event Organizer